These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 16027705)

  • 21. Utility of cardiovascular magnetic resonance in the diagnosis of Anderson-Fabry disease.
    Gange CA; Link MS; Maron MS
    Circulation; 2009 Sep; 120(13):e96-7. PubMed ID: 19786638
    [No Abstract]   [Full Text] [Related]  

  • 22. Nailfold capillaroscopy: Specific features in Fabry disease.
    Wasik JS; Simon RW; Meier T; Steinmann B; Amann-Vesti BR
    Clin Hemorheol Microcirc; 2009; 42(2):99-106. PubMed ID: 19433883
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An autopsy case of Fabry disease with neuropathological investigation of the pathogenesis of associated dementia.
    Okeda R; Nisihara M
    Neuropathology; 2008 Oct; 28(5):532-40. PubMed ID: 18410273
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fabry disease: case report with emphasis on enzyme replacement therapy and possible future therapeutic options.
    Möhrenschlager M; Pontz BF; Lanzl I; Podskarbi T; Henkel V; Ring J
    J Dtsch Dermatol Ges; 2007 Jul; 5(7):594-7. PubMed ID: 17610610
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic utility of different MRI and MR angiography measures in Fabry disease.
    Fellgiebel A; Keller I; Marin D; Müller MJ; Schermuly I; Yakushev I; Albrecht J; Bellhäuser H; Kinateder M; Beck M; Stoeter P
    Neurology; 2009 Jan; 72(1):63-8. PubMed ID: 19122032
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Fabry disease--a provocation for pediatrics].
    Hoffmann B; Mayatepek E
    Klin Padiatr; 2006; 218(1):38-40. PubMed ID: 16432775
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ocular features of Fabry disease: diagnosis of a treatable life-threatening disorder.
    Samiy N
    Surv Ophthalmol; 2008; 53(4):416-23. PubMed ID: 18572058
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Severe left ventricular hypertrophy in Anderson-Fabry disease.
    Bhatia GS; Leahy JF; Connolly DL; Davis RC
    Heart; 2004 Oct; 90(10):1136. PubMed ID: 15367506
    [No Abstract]   [Full Text] [Related]  

  • 29. [Anderson-Fabry disease].
    Kes P; Basić-Jukić N; Brunetta B; Jurić I
    Acta Med Croatica; 2006; 60(1):55-8. PubMed ID: 16802573
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CNS pathology and vascular/circulatory abnormalities in Fabry disease.
    Kolodny EH; Pastores GM
    Acta Paediatr Suppl; 2006 Apr; 95(451):55-6. PubMed ID: 16720466
    [No Abstract]   [Full Text] [Related]  

  • 31. Functional and structural nerve fiber findings in heterozygote patients with Fabry disease.
    Torvin Møller A; Winther Bach F; Feldt-Rasmussen U; Rasmussen A; Hasholt L; Lan H; Sommer C; Kølvraa S; Ballegaard M; Staehelin Jensen T
    Pain; 2009 Sep; 145(1-2):237-45. PubMed ID: 19665302
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Terminal stage cardiac findings in patients with cardiac Fabry disease: an electrocardiographic, echocardiographic, and autopsy study.
    Takenaka T; Teraguchi H; Yoshida A; Taguchi S; Ninomiya K; Umekita Y; Yoshida H; Horinouchi M; Tabata K; Yonezawa S; Yoshimitsu M; Higuchi K; Nakao S; Anan R; Minagoe S; Tei C
    J Cardiol; 2008 Feb; 51(1):50-9. PubMed ID: 18522775
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of uncontrolled hypertension in patients with Fabry disease.
    Kleinert J; Dehout F; Schwarting A; de Lorenzo AG; Ricci R; Kampmann C; Beck M; Ramaswami U; Linhart A; Gal A; Houge G; Widmer U; Mehta A; Sunder-Plassmann G
    Am J Hypertens; 2006 Aug; 19(8):782-7. PubMed ID: 16876675
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Magnetic resonance imaging changes in Fabry disease.
    Ginsberg L; Manara R; Valentine AR; Kendall B; Burlina AP
    Acta Paediatr Suppl; 2006 Apr; 95(451):57-62. PubMed ID: 16720467
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Surgical implications of the thickened pituitary stalk accompanied by central diabetes insipidus.
    Beni-Adani L; Sainte-Rose C; Zerah M; Brunelle F; Constantini S; Renier D; Lellouch-Tubiana A; Leger J; Pierre-Kahn A
    J Neurosurg; 2005 Aug; 103(2 Suppl):142-7. PubMed ID: 16370280
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuropathy and Fabry disease: pathogenesis and enzyme replacement therapy.
    Schiffmann R
    Acta Neurol Belg; 2006 Jun; 106(2):61-5. PubMed ID: 16898255
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fabry disease--evaluation by cardiac magnetic resonance imaging.
    Castela S; Azarine A; Mousseaux E
    Rev Port Cardiol; 2004 Dec; 23(12):1643-6. PubMed ID: 15732665
    [No Abstract]   [Full Text] [Related]  

  • 38. Anderson-Fabry disease: extrarenal, neurologic manifestations.
    Kolodny EH; Pastores GM
    J Am Soc Nephrol; 2002 Jun; 13 Suppl 2():S150-3. PubMed ID: 12068029
    [No Abstract]   [Full Text] [Related]  

  • 39. Central nervous system vasculopathy caused by Fabry disease: a case report.
    Kong DZ; Lian YH; Wang LJ; Wang CM; Meng YY; Zhou HW
    BMC Neurol; 2019 Jun; 19(1):115. PubMed ID: 31170963
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The kidney in Fabry disease.
    Raas-Rothschild A; Friedlaender MM; Pizov G; Backenroth R
    J Pediatr; 2005 Jan; 146(1):148. PubMed ID: 15644850
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.